Pedmark
Total Payments
$230,844
Transactions
1,349
Doctors
866
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $185,312 | 1,107 | 717 |
| 2023 | $45,532 | 242 | 179 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $171,413 | 41 | 74.3% |
| Food and Beverage | $51,397 | 1,295 | 22.3% |
| Travel and Lodging | $7,551 | 11 | 3.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $483.00 | 2 | 0.2% |
Top Doctors Receiving Payments for Pedmark — Page 35
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Hematology & Oncology | Fort Smith, AR | $13.54 | 1 |
| , M.D | Hematology & Oncology | Joliet, IL | $13.37 | 1 |
| , MD | Hematology & Oncology | Tinley Park, IL | $13.36 | 1 |
| , M.D | Medical Oncology | Effingham, IL | $13.27 | 1 |
| , FNP-C | Registered Nurse | Stewardson, IL | $13.26 | 1 |
| Grace Sund | Pediatrics | Santa Monica, CA | $13.20 | 1 |
| , N.P | Pediatrics | Los Angeles, CA | $13.20 | 1 |
| , MD | Hematology & Oncology | Louisville, KY | $13.12 | 1 |
| , MD | Internal Medicine | Louisville, KY | $13.12 | 1 |
| , M.D | Hematology & Oncology | San Marcos, CA | $13.11 | 1 |
| , D.O | Hematology & Oncology | San Diego, CA | $13.11 | 1 |
| , NURSE PRACTITIONER | Nurse Practitioner | San Marcos, CA | $13.11 | 1 |
| , MD | Internal Medicine | Oklahoma City, OK | $12.78 | 1 |
| , MD | Medical Oncology | Houston, TX | $12.16 | 1 |
| , D.O | Obstetrics & Gynecology | Albuquerque, NM | $11.93 | 1 |
| , M.D | Hematology & Oncology | Houston, TX | $10.98 | 1 |
| , MD | Internal Medicine | Saint Louis, MO | $10.90 | 1 |
Ad
Manufacturing Companies
- Fennec Pharmaceuticals, Inc. $230,844
Product Information
- Type Drug
- Total Payments $230,844
- Total Doctors 866
- Transactions 1,349
About Pedmark
Pedmark is a drug associated with $230,844 in payments to 866 healthcare providers, recorded across 1,349 transactions in the CMS Open Payments database. The primary manufacturer is Fennec Pharmaceuticals, Inc..
Payment data is available from 2023 to 2024. In 2024, $185,312 was paid across 1,107 transactions to 717 doctors.
The most common payment nature for Pedmark is "Consulting Fee" ($171,413, 74.3% of total).